Jacques Pierre Moreau
Directeur/Membre du Conseil chez Mulleris Therapeutics, Inc.
Postes actifs de Jacques Pierre Moreau
Sociétés | Poste | Début | Fin |
---|---|---|---|
Mulleris Therapeutics, Inc. | Directeur/Membre du Conseil | - | - |
Chondiothera, Inc. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jacques Pierre Moreau
Anciens postes connus de Jacques Pierre Moreau
Sociétés | Poste | Début | Fin |
---|---|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Directeur/Membre du Conseil | - | 03/02/2014 |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Directeur/Membre du Conseil | 24/06/2011 | 03/12/2012 |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | - | - | |
IPSEN | Directeur Technique/Scientifique/R&D | 01/01/1994 | - |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Directeur Général | 01/10/1976 | - |
Fondateur | 01/10/1976 | - | |
President | 01/10/1976 | - | |
DR. REDDY'S LABORATORIES LIMITED | Directeur/Membre du Conseil | 18/05/2007 | - |
Independent Dir/Board Member | 24/06/2011 | - |
Formation de Jacques Pierre Moreau
University of Orléans | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Inde | 2 |
2 |
Opérationnelle
Director/Board Member | 6 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
IPSEN | Health Technology |
Entreprise privées | 6 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
Mulleris Therapeutics, Inc. | |
Chondiothera, Inc. | |
Biomeasure, Inc.
Biomeasure, Inc. Pharmaceuticals: MajorHealth Technology Part of Ipsen SA, Biomeasure, Inc. researches, develops, and manufactures peptides and toxins for treating various conditions. The company is based in Milford, MA. The company was founded by Jacques Pierre Moreau. | Health Technology |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
- Bourse
- Insiders
- Jacques Pierre Moreau
- Expérience